BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nikolac Perkovic M, Videtic Paska A, Konjevod M, Kouter K, Svob Strac D, Nedic Erjavec G, Pivac N. Epigenetics of Alzheimer's Disease. Biomolecules 2021;11:195. [PMID: 33573255 DOI: 10.3390/biom11020195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gauvrit T, Benderradji H, Buée L, Blum D, Vieau D. Early-Life Environment Influence on Late-Onset Alzheimer’s Disease. Front Cell Dev Biol 2022;10:834661. [DOI: 10.3389/fcell.2022.834661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen Z, Wu M, Lai Q, Zhou W, Wen X, Yin X. Epigenetic regulation of synaptic disorder in Alzheimer’s disease. Front Neurosci 2022;16:888014. [DOI: 10.3389/fnins.2022.888014] [Reference Citation Analysis]
3 Peng R, Dong Y, Kang H, Guo Q, Zhu M, Li F. Identification of Genes with Altered Methylation in Osteoclast Differentiation and Its Roles in Osteoporosis. DNA Cell Biol 2022;41:575-89. [PMID: 35699379 DOI: 10.1089/dna.2021.0699] [Reference Citation Analysis]
4 Zhang T, Chen L, Guo X, Li S, He X, Pei S, Li D. N-3 polyunsaturated fatty acids prevent the D-galactose-induced cognitive impairment by up-regulating the levels of 5-hydroxymethylcytosine in the mouse brain. Food Funct 2022;13:4101-13. [PMID: 35316827 DOI: 10.1039/d1fo04420f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Miyan J, Buttercase C, Beswick E, Miyan S, Moshkdanian G, Naz N. Folate Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with Alzheimer’s Disease with a Change in Metabolic Profile. Metabolites 2022;12:475. [DOI: 10.3390/metabo12060475] [Reference Citation Analysis]
6 Dorado G, Gálvez S, Rosales TE, Vásquez VF, Hernández P. Analyzing Modern Biomolecules: The Revolution of Nucleic-Acid Sequencing - Review. Biomolecules 2021;11:1111. [PMID: 34439777 DOI: 10.3390/biom11081111] [Reference Citation Analysis]
7 Mao YM, Wang P, Wang XY, Ye DQ. Global Public Interest and Seasonal Variations in Alzheimer's Disease: Evidence From Google Trends. Front Med (Lausanne) 2021;8:778930. [PMID: 34957153 DOI: 10.3389/fmed.2021.778930] [Reference Citation Analysis]
8 Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M. Oxidative Stress and Beta Amyloid in Alzheimer's Disease. Which Comes First: The Chicken or the Egg? Antioxidants (Basel) 2021;10:1479. [PMID: 34573112 DOI: 10.3390/antiox10091479] [Reference Citation Analysis]
9 Chen L, Shen Q, Xu S, Yu H, Pei S, Zhang Y, He X, Wang Q, Li D. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34864677 DOI: 10.3233/JAD-215217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Riscado M, Baptista B, Sousa F. New RNA-Based Breakthroughs in Alzheimer's Disease Diagnosis and Therapeutics. Pharmaceutics 2021;13:1397. [PMID: 34575473 DOI: 10.3390/pharmaceutics13091397] [Reference Citation Analysis]
11 Qiu H, Weng Q. Screening of Crucial Differentially-Methylated/Expressed Genes for Alzheimer's Disease. Am J Alzheimers Dis Other Demen 2022;37:15333175221116220. [PMID: 35848539 DOI: 10.1177/15333175221116220] [Reference Citation Analysis]